Clinical Trials
59 trialsTraveraRTGx
Travera Inc
LICOSARH
Aesculap AG
SOLAR
Guardant Health, Inc.
EXoPERT EMERALD Clinical Study
EXoPERT
PREEMPT CRC
Freenome Holdings Inc.
FIND-CRC
Natera, Inc.
STAR-T
Bayer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
Exact Sciences Corporation
Metabiomics Colon Cancer Clinical Research Study
Metabiomics Corp
xDRIVE in Metastatic Colorectal Cancer
First Ascent Biomedical Inc.
OCEAN
Boryung Pharmaceutical Co., Ltd
CASCADE
Epiliquid Holding, Inc
eAArly DETECT
Mainz Biomed
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
K-ACCELERATE
Gene Solutions
BLOOMSI
OncoAtlas LLC
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
PROCEED-CRC
Natera, Inc.
ROOT
Taproot Health
QUANTUM
VitaMed Research LLC
RADIANT
DxTerity Diagnostics
MODEL-CRC
Xilis, Inc.
Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies
Ardigen
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
Singlera Genomics Inc.
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
A Prospective Single-Center Evaluation of SureFormâ„¢ Staplers in Robotic-assisted Colorectal Procedures
Intuitive Surgical
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
Natera, Inc.
Analyzing Clinical Trial Experiences of Colon Cancer Patients
Power Life Sciences Inc.
GASTROMO
Aesculap AG
PICOP-GLOBAL
CENTOGENE GmbH Rostock
ARIES
Genentech, Inc.
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Retrospective Analysis of Colorectal Cancer Screening Results
Creative Biosciences (Guangzhou) Co., Ltd.
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
Exact Sciences Corporation
Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia
Norgine
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Freenome Holdings Inc.
Development Study of Check-Cap Imaging System in Healthy Volunteers
Check-Cap Ltd.
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
Clinical Value of G-EYE Colonoscopy in Daily Practice for Adenoma Detection and Time for Polyp Removal
Dr. Horst Schmidt Klinik GmbH
Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
D1 Medical Technology (Shanghai) Co., Ltd, China
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Exact Sciences Corporation
Plasma-based Colorectal Cancer Screening Research & Development
Epigenomics, Inc
PIONEER
SpeciCare
ADOPTR
Proteus Digital Health, Inc.
PARSC
Agendia
A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer
Onkovis GmbH
Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
American BioOptics, LLC
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Cota Inc.
MMS-TM
MedInnovation GmbH